Generic Drugmaker Impax to Pay $145 Mln to Finish Opioid Antitrust Litigation – Newest Tweet by Reuters

Generic drugmaker Impax to pay $145 mln to end opioid antitrust litigation— Reuters (@Reuters) July 21, 2022

(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user’s social media account and LatestLY Staff may not have modified or edited the content body . The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)

Comments are closed.